SCIENTIFIC PROGRAM
Message to all registered / paid conference attendees:
Scientific Sessions will be made live every evening at midnight EST for registered/paid attendees and can be viewed any time during the conference period. Speakers and moderators will be available during IMED 2021 to engage with attendees and to answer questions via a Question/Answer tool.
Plenary Sessions and Question/Answer periods will be live (EST) and can be attended by registered/paid attendees.
ePosters will be listed once the actual virtual conference is live. Please make sure to view ePosters and engage with the presenters through the Q&A function.
All sessions and ePosters will be available for registered attendees for 3 months after conclusion of the conference.
All registered/paid attendees have been sent and should have received their login to access the virtual conference platform as of November 4, 2021. All sessions and ePosters will be available to registered attendees for three months on the virtual conference platform.
Virtual conference platform link (Access for registered attendees only: https://imedconference.isid.org/)
Time Converter web pages: https://www.worldtimebuddy.com or https://dateful.com/time-zone-converter
The program is subject to change.
Plenaries I Live Sessions:
PL01 I Plenary Session 01:
COVID-19 – How Far Have We Come, and Where Do We Go?
01:00 PM to 02:00 PM CET I 08:00 AM – 09:00 AM EST
After release, the plenary session will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Chair: Marjorie Pollack, ProMED Deputy Editor, USA
Speaker: Maria Van Kerkhove, World Health Organization, Geneva, Switzerland
PL02 I Plenary Session 02:
COVID-19, Ebola, Lassa Fever and More – Application of Genomics in Epidemic Surveillance and Response
Live Session and Q/A: 07:00 PM to 08:00 PM CET I 02:00 PM – 03:00 PM EST
After release, Live plenary sessions will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Chair: Adebola Olayinka, Nigeria Centre for Disease Control (NCDC), Nigeria
Speaker: Christian Happi, African Centre of Excellence for Genomics of Infectious Diseases at Redeemer’s University in Ede, Nigeria
Scientific Sessions:
SS01 I Scientific Session 01:
The Impact of Media and Politics on Outbreak Preparedness and Control
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: Devika Dixit, University of Saskatchewan & University of Calgary, Saskatoon and Calgary, Canada
• The Covid-19 Witch Hunt: Are Virologists at Risk?: Ilaria Capua, One Health Center of Excellence, University of Florida, Gainesville, Florida, USA
• The Role of the Media during the COVID-19 Pandemic in Hong Kong: Elizabeth Cheung, South China Morning Post, Hong Kong
• Mining Online and Social Media to Analyze Epidemic Periods: Mathieu Roche, CIRAD, France
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS02 I Scientific Session 02:
Global Health Security Risks
This session was developed in collaboration with the ESCMID Emerging Infections Task Force
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Chair: Scott McNabb, Emory University, Rollins School of Public Health, USA
• Strengthening Partnerships to Tackle Emerging Infectious Diseases: Mohammed Lamorde, Global Health Security Programme, Kampala, Uganda
• The Role of International Travel and Border Restrictions in Managing the Spread of Outbreaks: Eskild Petersen, Aarhus University, Institute for Clinical Medicine, Denmark
• Biosafety in Research on Potential Pandemic Pathogens: Nahid Bhadelia, Section of Infectious Diseases, Boston University, Boston, Massachusetts, USA
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS03 I Scientific Session 03:
Broadening the Evidence-base for Mitigating Risk of Emerging Disease: Knowledge Gaps and Research Challenges in the Face of Rapid Global Environmental Change
This session was developed in consultation with The US National Academies of Sciences, Engineering and Medicine
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderators: David Blazes, Bill and Melinda Gates Foundation, North Seattle, Washington, USA & Christine Kreuder Johnson, University of California – Davis, California, USA
• What Drives the Association Between Rainfall and Diarrhea – Interrogating Evidence in Support of the Concentration Dilution Hypothesis: Joseph Eisenberg, University of Michigan, School of Public Health, Ann Arbor, Michigan, USA
• Global Change and the Ecology of Vector-Borne Disease: Erin Mordecai, Stanford University, Stanford, California, USA
• Leveraging Wastewater Surveillance to Improve Health Security: David Larsen, Syracuse University, Syracuse, New York, USA
• Discussant: Andrew Clements, U.S. Agency for International Development, Washington, DC, USA
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS11 I Scientific Session 11:
Big Data for Pandemic Response: Ethical, Legal, and Regulatory Responsibilities
This session was developed in collaboration with the Rockefeller Foundation
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: Emily Bass, The Rockefeller Foundation’s Pandemic Prevention Institute, New York, USA
Discussants:
• Alexandra L. Phelan, Georgetown University Center for Global Health Science and Security, Washington, DC, USA
• Brian J. Honermann, amfAR– The Foundation for AIDS Research, Washington, DC, USA
• Elaine O. Nsoesie, Boston University School of Public Health, Boston, Massachusetts, USA
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Oral Abstract Sessions:
Submitted abstracts underwent a rigorous peer-review process. Highest scoring abstracts were selected for oral presentation – this constituted approximately 8% of all abstracts submitted for presentation at IMED 2021.
OP01 I Oral Abstract Presentations 01:
One Health – Emerging Threats across Species Boundaries
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Title: Serum Neutralisation profiles of Straw-Coloured Fruit Bats (Eidolon helvum) against four Lineages of Lagos Bat Lyssavirus
Speaker: Veronica Odinya Ameh, Federal University of Agriculture Makurdi, Makurdi, Benue State, Nigeria
Title: Trichinella britovi Outbreak in North-West Italy, 2019-2020: Beware of Wild Boar
Speaker: Giacomo Stroffolini, Amedeo di Savoia Hospital, Torino, Italy
Title: Evidence of Exposure to SARS-CoV-2 in Cats and Dogs in Luxembourg
Speaker: Chantal Snoeck, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
Title: Recovering Influenza Genomes from Wild Bird Habitats for Outbreak Prevention and Pandemic Preparedness
Speaker: Kevin Kuchinski, University of British Columbia, Vancouver, British Columbia, Canada
Title: Systems’ Barriers and Facilitators of One Health Programs that Address Zoonotic Diseases: A Review of the Literature
Speaker: Lisset Dumet Poma, OHSU-PSU School of Public Health, Portland, Oregon, USA
Title: Molecular Methodology for Tick Speciation and Tickborne Pathogen Surveillance
Speaker: Evangeline Green, University of New England College of Medicine, Biddeford, Maine, USA
Title: West Nile and Usutu Virus Circulation in Wild Birds and Equids in Piedmont, Liguria and Aosta Valley, Northwestern Italy, in 2018-2020
Speaker: Monica Marchino, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Turin, Italy
Title: High Prevalence of Rickettsia Slovaca in Dermacentor Marginatus in Euganean Hills Regional Park
Speaker: Laura Grassi, University of Padua, Legnaro, Padua, Italy
Title: Italy as a Hotspot of Usutu Virus in Europe
Speaker: Bianca Zecchin, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padova, Italy
Title: Results of Genotyping of the Congo-Crimean Hemorrhagic Fever Virus Circulating in Southern Kazakhstan
Speaker: Gulzhan Abuova, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
OP02 I Oral Abstract Presentations 02:
COVID-19: Surveillance, Diagnosis and Response
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Title: COVID-19 Cluster among 2020 Matric Rage Festival Attendees, KwaZulu-Natal Province, South Africa, November–December 2020
Speaker: Andronica Moipone Shonhiwa, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa
Title: Excess Deaths during COVID-19 Pandemic in Alberta, Canada
Speaker: Sanjay Beesoon, Alberta Health Services, Edmonton, Alberta, Canada
Title: Implementing a SARS-CoV-2 Early Warning System in Valencia (Spain) and its Correlation with Epidemiological Indicators
Speaker: Paloma Perez, Global Omnium, Valencia, Spain
Title: Co-circulation of SARS-CoV-2 Variants of Concern Alpha and Gamma in Italy
Speaker: Mattia Manica, Bruno Kessler Institute, Trento, Italy
Title: Colorimetric Reverse Transcriptional Loop-mediated Isothermal Amplification for Rapid Detection of SARS-CoV-2
Speaker: Praveen Rai, Nitte University Centre for Science Education and Research, Mangaluru, Karnataka, India
Title: Trends of a Syndromic Approached Based Respiratory PCR during the Second Wave of the COVID 19 Pandemic in a Tertiary Care Center in Mumbai
Speaker: Aruna Poojary, Breach Candy Hospital Trust, Mumbai, India
Title: Methods for Counting COVID-19 Deaths in U.S. States and Territories
Speaker: Quang Nguyen, The COVID Tracking Project at The Atlantic, Washington, DC, USA
Title: Assessing the Shift in Reasoning for COVID-19 Vaccine Hesitancy in the United States Using a Six-Month Cross-Sectional Analysis from December 2020 to June 2021
Speaker: Autumn Gertz, Boston Children’s Hospital, Boston, Massachusetts, USA
Title: Assessing the Epidemiological and Economic Impact of Alternative Vaccination Strategies: A Modeling Study
Speaker: Sooyoung Kim, New York University School of Global Public Health, New York, USA
Title: Tracking Changes in SARS-CoV-2 Transmission with a Novel Outpatient Sentinel Surveillance System in Chicago, Illinois, USA
Speaker: Reese Richardson, Northwestern University, Evanston, Illinois, USA
ePoster Presentations:
Submitted abstracts underwent a rigorous peer-review process. High scoring abstracts were selected for ePoster presentations. IMED 2021 will feature more than 300 ePosters across all areas of interest to registered IMED 2021 attendees.
ePoster presentations will be available to registered attendees only and include audio / video presentation options for presenting authors.
All accepted ePosters will be listed on the virtual conference platform and we encourage registered attendees to view ePosters at their leisure and engage with the presenters through the Q&A function.
After release, ePosters will be available for the duration of the meeting and for three months after conclusion of the meeting.
Plenaries I Live Sessions:
PL03 I Plenary Session 03:
Viruses in Bats and Potential Spillover to Animals and Humans
Live Session and Q/A: 01:00 PM to 02:00 PM CET I 08:00 AM – 09:00 AM EST
After release, Live plenary sessions will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Chair: Latiffah Hassan, Universiti Putra Malaysia, Malaysia
Speaker: Lin-fa Wang, Programme in Emerging Infectious Disease, Duke-NUS Medical School, Singapore
PL04 I Plenary Session 04:
Global Climate Change and Emerging Infectious Diseases
Live Session and Q/A: 07:00 PM to 08:00 PM CET I 02:00 PM – 03:00 PM EST
After release, Live plenary sessions will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Chair: Wondwossen Gebreyes, Global One Health Initiative (GOHI), Ohio State University, USA
Speaker: Kristie L. Ebi, Center for Health and the Global Environment, Department of Global Health, University of Washington, Seattle, Washington, USA
Scientific Sessions:
SS04 I Scientific Session 04:
Impact of Climate Change and Human Migration on Parasitic Infections
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Chair: Chadia Wannous, Towards a Safer World Network (TASW), Sweden
• Changes in the Epidemiology of Zoonotic Malaria in Southeast Asia: Balbir Singh, Universiti Malaysia Sarawak, Malaysia
• Global Changes in Epidemiology and Burden of Crimean Congo Hemorrhagic Fever: Hakan Leblebicioglu, VM Medicalpark Hospital, Infectious Diseases Department, Samsun, Turkey
• Impact of Climate and Environmental Changes on Leishmaniasis: Filipe Dantas-Torres, Department of Immunology, Instituto Aggeu Magalhães, Recife, Brazil
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS05 I Scientific Session 05:
Novel Applications for Earth Observation and Non-traditional Data Analytics for Public Health Impact at Scale
This session was developed in collaboration with The MITRE Corporation
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
• Monitoring of Harmful Algal Blooms Using Hyperspectral Remote Sensing: Natalie Hall, Florence Bascom Geoscience Center, US Geological Survey, USA
• Determining the Impact of Saharan dust on Public Health and COVID-19 Patients in Puerto Rico: Pablo A. Mendez Lazaro, PR-CLIMAH, University of Puerto Rico, Puerto Rico
• Anomaly Detection in Climate Data to Drive Rift Valley Fever Modeling: Assaf Anyamba, Goddard Earth Science and Technology Research, NASA, USA
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS06 I Scientific Session 06:
Panel Discussion: Participatory Surveillance: How Communities are Finding and Responding to Outbreaks Faster
This session was developed in collaboration with Ending Pandemics
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: Mark Smolinski, Ending Pandemics, San Francisco, California, USA
Discussants:
• Esron Karimuribo, Sokoine University of Agriculture (SUA), Morogoro, Tanzania
• Gustav Praekelt, Praekelt Group, Johannesburg, South Africa
• Channé Suy, inSTEDD iLab Southeast Asia, Phnom Penh, Cambodia
• Terdsak Yano, Chiang Mai University, Chiang Mai, Thailand
• Sakulrat Pattamakaew, PODD Centre, Chiang Mai University, Chiang Mai, Thailand
• Onicio Leal Neto, EpiTrack (Brazil) & University of Zurich (Guardians of Health Project)
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS07 I Scientific Session 07:
Panel Discussion: Transforming One Health Education During the Pandemic
This session was developed in collaboration with Southeast Asia One Health University Network (SEAOHUN)
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: Vipat Kuruchittham, Southeast Asia One Health University Network (SEAOHUN), Thailand
Discussants:
• Agus Suwandono, Indonesia One Health University Network (INDOHUN), Indonesia
• Razitasham Safii, Malaysia One Health University Network (MyOHUN), Malaysia
• Saengduen Moonsom, Thailand One Health University Network (THOHUN), Thailand
• Pham Duc Phuc, Vietnam One Health University Network (VOHUN), Vietnam
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Oral Abstract Sessions:
Submitted abstracts underwent a rigorous peer-review process. Highest scoring abstracts were selected for oral presentation – this constituted approximately 8% of all abstracts submitted for presentation at IMED 2021.
OP03 I Oral Abstract Presentations 03:
Outbreak Preparedness and Response
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Reserved for the best submitted abstracts in the, “Outbreak Preparedness and Response” category.
Title: Structural-Equation-Modelling (SEM) to Analyze Climatic Factor’s Role on COVID-19 Spreading
Speaker: Alessia Spada, University of Foggia, Foggia, Italy
Title: Concept of Resampling: Protocol for the Field-based Detection and Characterization of the European Filovirus (Lloviu cuevavirus)
Speaker: Gabor Toth, University of Pécs, Pécs, Baranya, Hungary
Title: The Use of Culture, Molecular Methods and Whole Genome Sequencing to Detect the Source of an Outbreak of Legionnaire’s Disease in New York State
Speaker: Danielle Wroblewski, Wadsworth Center, NYSDOH, Albany, New York, USA
Title: Meshing Biosurveillance and Climate Data to Inform Chikungunya Disease Surveillance
Speaker: Assaf Anyamba, Universities Space Research Association, Columbia, Maryland, USA
Title: Assessing Effectiveness of Ring Vaccination in Mitigating a Mumps Outbreak on a College Campus
Speaker: Omotoyosi Soniyi, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Title: A Pilot Study on the Serostatus of Parvovirus B19 in Blood Donors at a Tertiary Healthcare Centre in South India
Speaker: Swati Kumari, Sri Ramachandra Institute of Higher Education & Research Centre, Chennai, Tamilnadu, India
Title: Rubella Epidemiology in the Central African Republic, 2015-2016 and Molecular Characterization of Virus Strains from 2008-2016
Speaker: Marilou Pagonendji, Institut Pasteur de Bangui, Bangui, Central African Republic
Title: Using an AEFI Parent Diary Card following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries
Speaker: Courtney Sciarratta, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Title: High Serological Evidence of Human Papillomavirus Type 16 Infection in Women of Child-Bearing Age in Central Nigeria
Speaker: Rine Reuben, Anchor University, Biological Sciences, Lagos, Nigeria
Title: Detection of Dengue Virus Serotype 3 in Cajamarca, Peru: Molecular Diagnosis and Clinical Characteristics
Speaker: Hugo Carrillo-Ng, Instituto de Investigación Nutricional, Lima, Peru
OP04 I Oral Abstract Presentations 04:
COVID-19: Hot Topics
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Title: COVID-19 in People Living with HIV
Speaker: Larisa Ermakova, Rostov Research Rostov Research Institute of Microbiology and Parasitology, Rostov-on-Don, Russian Federation
Title: Assessment of High-Titer Convalescent Plasma as an Adjunctive Therapy in the Reduction of Mortality Rate and Viral Load in Patients with Severe COVID-19: A Meta-Analysis
Speaker: Mikaella Ramos, University of Santo Tomas, Sampaloc, Manila, Metro Manila, Philippines
Title: Investigation of SARS-CoV-2 RNAemia in the Convalescent Plasma of COVID-19 Patients
Speaker: Nagaraj Perumal, Gandhi Medical College, Bhopal, Madhya Pradesh, India
Title: Emerging COVID-associated Mucor-Aspergillosis – A Need of Separate Definition
Speaker: Vanya Singh, AIIMS Rishikesh, Dehradun, Uttarakhand, India
Title: Characterization of the Nasopharyngeal Microbiota of COVID-19 Patients According to Disease Severity
Speaker: Hugo Carrillo-Ng, Instituto de Investigación Nutricional, Lima, Peru
Title: Risk Factors Associated with the Mucormycosis Epidemic during the COVID-19 Pandemic
Speaker: Kundakarla Bhanuprasad, Vellore Christian Medical College And Hospital, Vellore, Tamil Nadu, India
Title: Implementing Non-Pharmaceutical Interventions to prevent the spread of COVID-19 in slums and overcrowded housing settings: A cogent factor that may fuel resurgence of the pandemic waves
Speaker: Sabdat Ekama, Nigerian Institute of Medical Research, Lagos, Nigeria
Title: COVID-19 Associated Invasive Fungal Rhinosinusitis: A Retrospective Analysis of 15 Cases
Speaker: Vettakkara Kandy Muhammed Niyas, KIMSHEALTH, Thiruvananthapuram, Kerala, India
Title: Prediction of Hospital-onset COVID-19 using Networks of Patient Contact: An Observational Study
Speaker: Ashleigh Myall, Imperial College London, London, United Kingdom
Title: Investigating SARS-CoV-2 Test Positivity Calculations Across US Jurisdictions
Speaker: Jessica Rivera, The COVID Tracking Project at The Atlantic, Washington, DC, USA
ePoster Presentations:
Submitted abstracts underwent a rigorous peer-review process. High scoring abstracts were selected for ePoster presentations. IMED 2021 will feature more than 300 ePosters across all areas of interest to registered IMED 2021 attendees.
ePoster presentations will be available to registered attendees only and include audio / video presentation options for presenting authors.
All accepted ePosters will be listed on the virtual conference platform and we encourage registered attendees to view ePosters at their leisure and engage with the presenters through the Q&A function.
After release, ePosters will be available for the duration of the meeting and for three months after conclusion of the meeting.
Plenaries I Live Sessions:
PL05 I Plenary Session 05:
The Next Pandemic – A Look into the Future
Live Session and Q/A: 01:00 PM to 02:00 PM CET I 08:00 AM – 09:00 AM EST
After release, Live plenary sessions will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Chair: Paul Anantharajah Tambyah, National University of Singapore, Singapore
Speaker: Shahid Jameel, Trivedi School of Biosciences, Ashoka University, India
PL06 I Plenary Session 06:
COVID-19 Vaccinations for Children – A Global Discussion
Live Session and Q/A: 07:00 PM to 08:00 PM CET I 02:00 PM – 03:00 PM EST
After release, Live plenary sessions will be available on demand for registered attendees for the duration of the meeting and for three months after conclusion of the meeting.
Moderator: Miguel O’Ryan, Faculty of Medicine, University of Chile, Santiago, Chile
Discussants:
• Juan Pablo Torres, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
• Helena Maltezou, Department for Interventions in Health Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece
• Lee Le Ye, Department of Neonatology, National University Health System (NUHS) & Yong Loo Lin School of Medicine, NUS, Singapore
• Walter A. Orenstein, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA
Scientific Sessions:
SS08 I Scientific Session 08:
Panel Discussion: Origins of SARS-CoV-2
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: David Relman, Stanford University, Stanford, California, USA
Discussants:
• Marion Koopmans, Erasmus MC Department of Viroscience, Netherlands
• Veasna Duong, Institut Pasteur, Cambodia
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS09 I Scientific Session 09:
One Health in Action
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Chair: Tom Yuill, University of Wisconsin, Madison, Wisconsin, USA
• Avian Influenza in the time of COVID-19: Stories from Cambodia: Erik Karlsson, National Influenza Center of Cambodia and H5 Reference Laboratory, WHO Global COVID-19 Referral Laboratory, Institut Pasteur, Phnom Penh, Cambodia
• Mers-CoV: Malik Peiris, Chair of Virology, Division of Public Health Laboratory Sciences, The University of Hong Kong, Hong Kong
• One Health Response to Antimicrobial Resistance: Latiffah Hassan, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Malaysia One Health University Network, Selangor, Malaysia
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
SS10 I Scientific Session 10:
The Program for Monitoring Emerging Diseases (ProMED) Moderators’ Experiences with the COVID-19 Pandemic
This session was developed in collaboration with ProMED
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST*
Moderator: Yaw Afrane, Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Accra, Ghana
Discussants:
• Aisha Abubakar, Ahmadu Bello University Zaria/Ahmadu Bello University Teaching Hospital Zaria, Zaria, Nigeria
• Pablo Beldomenico, Disease Ecology Laboratory – Instituto de Ciencias Veterinarias del Litoral, Universidad Nacional del Litoral – Consejo Nacional del Investigaciones Científicas y Técnicas, Chaco Chico, Santa Fe Province, Argentina
• Kassim Jimale, VP Research & Development, Jamhuriya University of Science and Technology, Mogadishu, Somalia
• Cristina David, Animal Health Consultant, Ellicott City, Maryland, USA
• Batyrbek Aslanov, North-Western State Mechnikov Medical University, St. Petersburg, Russian Federation
*After session release, sessions will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Closing Remarks:
• Closing remarks from ISID’s CEO, Linda MacKinnon & IMED highlights from Julia Maxwell, ISID’s Director of Disease Surveillance
• Tribute to ProMED’s long standing Editor, Dr. Larry Madoff, by ISID’s past Presidents
• Exciting Announcement about ISID’s upcoming International Congress on Infectious Diseases in 2022 with ISID’s Executive Committee Member, Zamberi Sekawi
• ProMED Moderator Farewell
Oral Abstract Sessions:
Submitted abstracts underwent a rigorous peer-review process. Highest scoring abstracts were selected for oral presentation – this constituted approximately 8% of all abstracts submitted for presentation at IMED 2021.
OP05 I Oral Abstract Presentations 05:
Late-Breaker Abstracts
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Title: Vaccination May Not Have a Significant Impact on Super Spreading Events
Speaker: Haziq Nasir, National University Hospital, Singapore
Title: Estimating SARS-CoV-2 Prevalence from Large-scale Wastewater Surveillance: Insights from Combined Analysis of 44 sites in England
Speaker: Kathleen O’Reilly, LSHTM, London, United Kingdom
Title: Successful Reversal of the 2020 Covid-19 Response Induced Collateral Damage on Malaria Control in Saudi Arabia
Speaker: Shamsudeen Fagbo, King Fahad Medical City, Riyadh, Saudi Arabia
Title: Development of Highly Sensitive DENV NS1 Antigen Detection Immunoassay
Speaker: Farha Mehdi, Translational Health Science and Technology Institute, Faridabad, Haryana, India
Title: Severe Acute Respiratory Infection Collaborative surveillance and Monitoring Outbreak, Viet Nam
Speaker: Tuan Le, Nguyen Tat Thanh University, Ho Chi Minh, Viet Nam
Title: SARS-CoV-2 Variants Detection Using TaqMan SARS-CoV-2 Mutation Panel Molecular (Genotyping) Assays
Speaker: Puja Neopane, Patients Choice Laboratories, Indianapolis, Indiana, USA
Title: Yellow Fever Outbreak Investigation-Enugu State, Nigeria, November 2020
Speaker: Peter Amede, AFENET, Abuja, Nigeria
Title: Novel Application of Capture-Recapture Methods to Estimate the Completeness of Contact Tracing During a Large Outbreak of Ebola Virus Disease, Democratic Republic of Congo, 2018-2020
Speaker: Jonathan Polonsky, World Health Organization, Geneva, Switzerland
Title: Extensively Drug-Resistant Salmonella enterica serovar Typhi in Pediatric population during CoVID-19 Pandemic
Speaker: Maria Khan, Rehman Medical Institute, Peshawar, Pakistan
OP06 I Oral Abstract Presentations 06:
Antimicrobial Resistance, Infection Prevention and Control
Available starting at 5:00 AM to 6:00 AM CET I 12:00 AM midnight – 01:00 AM EST
After release, presentations will be available for the duration of the meeting and for three months after conclusion of the meeting. Speakers will be available to answer questions and engage with attendees for the duration of the meeting via the IMED 2021 Question & Answer tool.
Title: Introducing ProMED-AMR
Speaker: Sophie Bowman-Derrick, Program for Monitoring Emerging Diseases (ProMED), International Society for Infectious Diseases, Northern Territory, Australia
Title: Distribution of blaOXA Genes among Malaysian Burkholderia pseudomallei Isolates and Correlation with Patient Outcome
Speaker: Revathy Arushothy, Institute for Medical Research, Shah Alam, Selangor, Malaysia
Title: A First Large-Scale Monitorization Report Highlighting Exotic Pets As An Emergent Reservoir of MultiDrug Resistant Bacteria (Toulouse, France)
Speaker: Eduarda Silveira, University School Vasco da Gama, Coimbra, Portugal
Title: Acquired resistome and plasmid sequencing of mcr-1 carrying multi-drug resistant Enterobacterales from poultry and their potential transmissibility to humans
Speaker: Ghassan Matar, American University of Beirut, Beirut, Lebanon
Title: Low Macrolide and Fluoroquinolone Susceptibility in Non-pathogenic Neisseriae in the General Belgian Population and STI Clinic Attendees
Speaker: Christophe Van Dijck, Institute of Tropical Medicine Antwerp, Antwerp, Belgium
Title: Antimicrobial Susceptibility Profile of Healthcare-Associated Methicillin Resistant Staphylococcus aureus with Special Reference to Vancomycin and Ceftaroline
Speaker: Sreejisha M, Kasturba Medical College, A Constituent Unit of Manipal Academy of Higher Education, Mangalore, Karnataka, India
Title: Achieving Success by Validation! Decontamination Protocols of Category A Medical Waste for Patients with Serious Communicable Diseases
Speaker: Jessica Tarabay, Emory Healthcare, Atlanta, Georgia, USA
Title: Evaluation of Antibiotic Use in Inpatients at the Evangelical Medical Institute of Kimpese Hospital, Democratic Republic of Congo
Speaker: Mi Budiongo, Institut Médical Evangélique de Kimpese/ Centre de Recherche en Santé de KImpese, Cité de Kimpese, Ville de Bangu, Congo, D.R.
Title: Effects of Antibiotic Treatment on Antimicrobial Resistance in Pig Microbiomes: a Longitudinal Study
Speaker: Ruchita Balasubramanian, University of Cambridge, Cambridge, United Kingdom
ePoster Presentations:
Submitted abstracts underwent a rigorous peer-review process. High scoring abstracts were selected for ePoster presentations. IMED 2021 will feature more than 300 ePosters across all areas of interest to registered IMED 2021 attendees.
ePoster presentations will be available to registered attendees only and include audio / video presentation options for presenting authors.
All accepted ePosters will be listed on the virtual conference platform and we encourage registered attendees to view ePosters at their leisure and engage with the presenters through the Q&A function.
After release, ePosters will be available for the duration of the meeting and for three months after conclusion of the meeting.